HALO logo
halo search icon
Cardiol Therapeutics Inc. Class A

US$1.30

Price Change Indicator
0.04 (3.18%)
Cardiol Therapeutics Inc. Class A
CRDL · NAS

Cardiol Therapeutics Inc. Class A

Start Trading CRDL for Free

US$1.30

Price Arrow0.04 (3.18%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cardiol Therapeutics Inc. Class A Overview

CRDL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CRDL

icon

Website

Cardiol Therapeutics Inc. Class A

icon

Telephone

1.289.910.0850

icon

Address

Suite 602, 2265 Upper Middle Road East, Oakville, ON L6H 0G5

Description

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the "ARCHER" trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

CRDL Price Chart

Key Stats

Market Cap

US$141.36M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.88 - 1.71

Trade Value (12mth)

US$178,278.00

1 week

-4.55%

1 month

-22.7%

YTD

26.74%

1 year

18.87%

All time high

10.00

Key Fundamentals

EPS 3 yr Growth

-26.80%

EBITDA Margin

0.00%

Operating Cashflow

-$17m

Free Cash Flow Return

-112.40%

ROIC

-159.30%

Interest Coverage

0.00

Quick Ratio

4.20

Other Data

Shares Outstanding (Fully Diluted)

109m

HALO Sector

Healthcare

Next Company Report Date

05-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CRDL Announcements

Latest Announcements

DateAnnouncements
14 May 26
12 May 26
07 May 26
28 April 26
14 April 26

CRDL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.32-0.37-0.28locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.32-0.37-0.28locklocklock
Growth
 %locklocklocklock14.9-15.725.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cardiol Therapeutics Inc. Class A (CRDL:NAS)?
Halo FAQ
The current share price of Cardiol Therapeutics Inc. Class A (CRDL:NAS) is USD$1.30.
What is the 52-week high share price for Cardiol Therapeutics Inc. Class A (CRDL:NAS)?
Halo FAQ
The 52-week high share price for Cardiol Therapeutics Inc. Class A (CRDL:NAS) is USD$1.71.
What is the 52-week low share price for Cardiol Therapeutics Inc. Class A (CRDL:NAS)?
Halo FAQ
The 52-week low share price for Cardiol Therapeutics Inc. Class A (CRDL:NAS) is USD$0.88.
What is the dividend yield for Cardiol Therapeutics Inc. Class A (CRDL:NAS)?
Halo FAQ
Cardiol Therapeutics Inc. Class A (CRDL:NAS) does not pay a dividend.
What was Cardiol Therapeutics Inc. Class A (CRDL:NAS) last dividend payment?
Halo FAQ
Cardiol Therapeutics Inc. Class A (CRDL:NAS) does not pay a dividend.
What is the franking level for Cardiol Therapeutics Inc. Class A (CRDL:NAS)?
Halo FAQ
Cardiol Therapeutics Inc. Class A (CRDL:NAS) has a franking level of 0.00%.
In which sector is Cardiol Therapeutics Inc. Class A (CRDL:NAS) classified?
Halo FAQ
Cardiol Therapeutics Inc. Class A (CRDL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial